🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2 peptide receptor radionuclide therapy trial of 90Y-DOTATO...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2017-09-29
Trial ID
NCT03273712
This is a Phase 2 peptide receptor radionuclide therapy trial of 90Y-DOTATO...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-01
Trial ID
NCT03013387
Treatments Being Tested
The rationale behind the purpose of this study lays on: * the evidence tha...
Status
Unknown
Location
University Hospital of Ferrara
Start Date
2018-07-02
Trial ID
NCT04790708
Peptide Receptor Radionuclide Therapy (PRRT) is based on specific somatosta...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2020-03-09
Trial ID
NCT04385992
Treatments Being Tested
This is a prospective, single arm,single centre open-label, phase II study ...
Status
Terminated
Location
Nuclear Medicin Division, IRST IRCCS
Start Date
2016-12-22
Trial ID
NCT02488512
Treatments Being Tested
This is a prospective, pilot, single center, open-label study in patients w...
Status
Completed
Location
University of California, San Francisco
Start Date
2017-07-01
Trial ID
NCT03197012
Treatments Being Tested
This is a safety study to determine the phase 1 starting dose of \[90\]Yttr...
Status
Terminated
Location
The Holden Comprehensive Cancer Center
Start Date
2018-10-11
Trial ID
NCT03724409
Treatments Being Tested
Neuroendocrine tumors (NETs) are relatively rare tumors, mainly originating...
Status
Terminated
Location
Chiara Maria Grana
Start Date
2020-09-15
Trial ID
NCT05568017
Treatments Being Tested
This is a Phase I/II peptide receptor radiotherapy (PRRT) trial of 177Lu-DO...
Status
Withdrawn
Location
University of Iowa Hospitals and Clinics
Start Date
2020-08-04
Trial ID
NCT03923257
Treatments Being Tested
This study is designed to identify the best tolerated doses of \[131\]Iodin...
Status
Active Not Recruiting
Location
Holden Comprehensive Cancer Center
Start Date
2017-05-07
Trial ID
NCT03044977
Treatments Being Tested